An observational study in Respiratory Distress Syndrome, sponsored by University of Campania Luigi Vanvitelli. Status unknown at 1 site in Italy. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2021-05-04.
Sponsored by University of Campania Luigi Vanvitelli · Observational
Lung Ultrasound (LUS) has been revealing an extremely useful tool to identify and monitor complications from Sars-COV-2 disease. Recently, a research group has proposed a score, named LUS Score, able to optimize the use of this diagnostic technique. LUS Score is computed analyzing chest posterior and lateral spaces, considering the number of artefacts generated by the inflammed interstitium (B lines), the characteristics of the pleural line and the presence or not of consolidation areas.
The comparison between LUS and chest tomography (CT), the current gold standard for the diagnosis of interstitial pneumonia by COVID-19, has confirmed from the preliminary data, the reliability of such technique. Hence, the validation on a really large sample size of the ultrasound tool performed by dedicated personnel with high expertise, may allow the validation both in the clinical practice and in emergency and ordinary wards.
1,597 studies on the registry are indexed under Respiratory Distress Syndrome; 312 are open to participants now.
This study's enrollment of 950 is above the median of 100 across 540 observational studies indexed under Respiratory Distress Syndrome.
Browse Respiratory Distress Syndrome studies →University of Campania Luigi Vanvitelli is the lead sponsor of 170 studies on the registry; 26 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients hospitalized due to COVID19 infection
Exclusion Criteria:
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Diagnostic Test: lung ultrasound
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Diagnostic Test: lung ultrasound
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Diagnostic Test: lung ultrasound
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Diagnostic Test: lung ultrasound
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Diagnostic Test: lung ultrasound
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Diagnostic Test: lung ultrasound
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Diagnostic Test: lung ultrasound
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Diagnostic Test: lung ultrasound
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Diagnostic Test: lung ultrasound
the patients underwent to a non invasive diagnostic exam to identify and monitor clinical conditions and onset of respiratory complications due to COVID-19
validation of lung ultrasound score
validation of lung ultrasound in the clinical practice of diagnosis of complications of low respiratory tracts during COVID-19
Time frame: 6 months
Association of LUS score with clinical outcome
assessment of LUS score association with the clinical course of disease (final outcome, either discharged or in-hospital mortality
Time frame: 6 months
Association of LUS score with duration of hospitalization (days)
assessment of LUS score association with hospitalization days
Time frame: 6 months
Association of LUS score with respiratory support required
assessment of LUS score association with requirement of either sub-intensive or intensive therapy)
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in May 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Respiratory Distress Syndrome→
University of Campania Luigi Vanvitelli